LT-010366

N/A

Report date: 2025/09/28 09:50:55
NME

Base Information

Drug NameLT-010366
Drug Alias NameLT-010366LT-010-366
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionKRAS G12D degraders
TargetsKRAS G12D
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Leadingtac Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Leadingtac Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A